The information contained within this announcement is deemed
by the Company to constitute inside information stipulated under
the Market Abuse Regulation (EU) No. 596/2014 as it forms part
of UK domestic law by virtue of the European Union (Withdrawal) Act
2018. Upon the publication of this announcement via
the Regulatory Information Service, this inside information is now
considered to be in the public domain.
9 December 2024
Hydrogen Utopia International
PLC
(the 'Company' or 'HUI')
Ohrid Organics - €450,000
Sale and Update
Hydrogen Utopia International PLC, a
company specialising in converting non-recyclable mixed waste
plastic into hydrogen and other carbon-free fuels, new materials or
distributed renewable heat, is pleased to inform shareholders that
Ohrid Organics DOO ("Ohrid Organics DOO"), based in North
Macedonia, has completed the sale of €450,000 worth of THC medical
cannabis. Payment will be in advance of shipment. Ohrid Organics
DOO is the subsidiary of Ohrid Organics Limited ("Ohrid Organics"),
the UK holding company.
As announced on 2 January 2024, HUI
exercised its option to acquire 49 % of Ohrid Organics,
anticipating Ohrid Organics to generate substantial future
cashflows for its shareholders and which HUI would utilise in
developing its pipeline of waste plastic to hydrogen plants.
HUI understands that further sales are expected to take place,
particularly due to the following developments:
(i)
|
The board of Ohrid Organics DOO is
negotiating with several potential offtake customers. Any such
offtake agreements would be in addition to Ohrid Organics DOO's
existing supply agreement with Canopy Growth Germany GmbH, a
subsidiary of Canopy Growth Corporation, announced on 11 July
2024.
|
(ii)
|
Given the current interest in the
Ohrid Organics DOO facility and its products, the board of Orhid
Organics has decided to pursue a targeted fundraising to accelerate
the facility's capacity. HUI understands that there are ongoing
discussions with several parties interested in providing funding to
facilitate this expansion in 2025. A 2 year £1 million
convertible loan note with a coupon of 14% per annum payable yearly
is currently envisaged.
|
Ohrid Organics DOO holds a license
to operate the largest cultivation area in North Macedonia, giving
it the leverage needed to meet the rising demand for medical
cannabis in Europe and across the globe. Over the course of this
year, Ohrid Organics DOO has focused on expanding its facilities
and has increased its cultivation area by 50%. It now operates six
greenhouses, each covering 500 square meters, for a total
cultivation area of 3,000 square meters. Even with this expansion,
Ohrid Organics DOO's facility only utilises 17% of Ohrid Organics
DOO's licensed area. The licensed area has the potential to
accommodate up to 37 greenhouses, enabling production of up to 30
tonnes per year across 20,000 square meters of cultivation area.
Over the past six months, Ohrid Organics DOO has trialled strains
from certain selected breeders, collecting data on the strains'
performance in Ohrid Organics DOO's environment and selecting those
strains capable of delivering the targeted effects.
The genetic strains selected and
cultivated at the start of 2024 did not perform as positively as
expected. Ohrid Organics DOO underwent significant changes within
its management, bringing in top-tier performers fully committed to
the facility's success. These changes, while necessary, caused
delays in commercial production and impacted the overall target
output for the year, resulting in the postponement of the
anticipated year-end turnover. HUI understands from the board
of Ohrid Organics
that the challenges have been identified and resolved.
Additionally, the board of Ohrid
Organics confirmed that the three strains
currently being cultivated on a commercial scale by
Ohrid Organics DOO are
expected to deliver consistent quality and achieve the desired
effects. Ohrid Organics anticipates that the delay in turnover for 2024 will
be partially offset in 2025.
Several structures for the
acquisition of 49% of Ohrid Organics are being considered, and HUI
is exploring its options.
Aleksandra Binkowska, CEO of HUI,
commented: "I am delighted with the
€450,000 sale of
Ohrid Organics' medicinal cannabis, marking a step forward for HUI
in achieving its objectives. While I acknowledge that this figure
falls short of expectations, I am confident that we will make up
for it next year thanks to the outstanding new management team and
the valuable relationships recently established. The original
agreement between HUI and Ohrid Organics stipulated that HUI would
not take part in managerial decisions. However, circumstances
necessitated our intervention and significant changes were
implemented, including the removal of underperforming individuals
from the management in order to safeguard shareholder value. These
individuals contributed to delays, but we are now back on track
with a highly capable team, fully focused on regaining lost ground
and ensuring maximum returns. With highly experienced professionals
now leading the effort, Ohrid Organics DOO successfully completed
its first sale and secured a contract that is expected to offset
the losses incurred in 2024 and accelerate the Ohrid Organics
program. HUI and Ohrid Organics remain closely linked, with HUI's
primary objective being the funding and development of its first
plastic waste-to-hydrogen facility, which continues to be our
primary focus."
For further information, please
contact:
Hydrogen Utopia International PLC
Aleksandra
Binkowska
+44 20 3811
8770
Alfred Henry Corporate Finance Limited (LSE Corporate
Adviser)
Nick Michaels/Maya Klein
Wassink
+44 (0) 20 8064 4056
Novum Securities Limited (Broker)
Jon Belliss/Colin
Rowbury
+44 20 7399 9400
About Hydrogen Utopia International PLC
HUI aims to become one of the
leading new European companies specialising in turning
non-recyclable mixed waste plastic into carbon-free fuels, new
materials or distributed renewable heat.
A HUI facility uses non-recyclable
mixed waste plastic as feedstock and turns it into syngas from
which new products and energy can be produced. HUI anticipates that
its revenues will be derived from a variety of sources, dependent
upon location and configuration of the HUI facilities, including
the sale of syngas, hydrogen and other gases, electricity and heat
sales, and the payment to it of fees for a given quantity of
non-recyclable mixed waste plastic received at a HUI
facility.
HUI will target areas where there is
significant private sector interest or potential, financial backing
is accessible and or where substantial EU and/or government funded
sources of grants and loans are or may be available. The global
increase in fossil fuel-based energy prices reinforces the need for
alternative, price competitive energy sources, which
HUI's business model
can provide.
The pressing need to deal with
growing amounts of waste plastic combined with a real momentum in
the use of hydrogen from renewable sources may pave the way for a
rapid deployment of and investment in HUI facilities.